These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2430157)

  • 1. Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid.
    Scheinin H; Virtanen R
    Life Sci; 1986 Oct; 39(16):1439-46. PubMed ID: 2430157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits.
    Dillen L; Claeys M; De Potter WP
    Eur J Pharmacol; 1987 May; 137(1):33-40. PubMed ID: 2440704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid.
    Scheinin H
    J Neurochem; 1986 Sep; 47(3):665-7. PubMed ID: 3016178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha 2-Adrenoceptor agonists decrease free 3-methoxy-4-hydroxyphenylglycol in rat cerebrospinal fluid.
    Scheinin H; Virtanen R; Scheinin M
    Eur J Pharmacol; 1986 Apr; 123(1):115-21. PubMed ID: 2872072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive measurement of monoamine metabolite levels in cerebrospinal fluid of conscious rats: effects of reserpine and haloperidol.
    Scheinin H; Scheinin M
    Eur J Pharmacol; 1985 Jul; 113(3):345-51. PubMed ID: 2412847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of parameters for central neuronal activity in cerebrospinal fluid of rabbits following yohimbine.
    Dillen L; Claeys M; De Potter WP
    Biochem Pharmacol; 1986 Nov; 35(22):3977-82. PubMed ID: 2430573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected ion monitoring analysis of monoamine metabolites in cerebrospinal fluid. Application to the study of in vivo effects of alpha 2-antagonists.
    Dillen L; Duchateau A; De Potter WP; Claeys M
    Biomed Environ Mass Spectrom; 1987 Nov; 14(11):675-82. PubMed ID: 2892549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 95(3):413-7. PubMed ID: 2901129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of yohimbine increases free 3-methoxy-4-hydroxyphenylglycol in the cerebrospinal fluid of the rat.
    Mignot E; Laude D; Elghozi JL; Le Quan-Bui KH; Meyer P
    Eur J Pharmacol; 1982 Sep; 83(1-2):135-8. PubMed ID: 6182009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity.
    Parfitt KD; Freedman R; Bickford-Wimer PC
    Brain Res; 1988 Oct; 462(2):242-51. PubMed ID: 2847850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the alpha 2-adrenoceptor antagonists yohimbine and idazoxan on kidney function in intact and diabetes insipidus rats.
    Farjam A; Greven J
    Urol Int; 1989; 44(5):255-9. PubMed ID: 2572085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin (PRL) release-inhibiting properties of the alpha 2 adrenergic receptor antagonist idazoxan: comparison with yohimbine.
    Krulich L; Jurcovicová J; Le T
    Life Sci; 1989; 44(12):809-18. PubMed ID: 2565008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolite levels in rat CSF: kinetic studies.
    Scheinin H; Scheinin M
    Pharmacol Toxicol; 1987 Sep; 61(3):167-71. PubMed ID: 2446306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 96(2):243-9. PubMed ID: 2906748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920.
    Meltzer LT; Wiley JN; Heffner TG
    Eur J Pharmacol; 1989 Oct; 170(1-2):105-7. PubMed ID: 2575523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of idazoxan on catecholamine systems in rat brain.
    Walter DS; Flockhart IR; Haynes MJ; Howlett DR; Lane AC; Burton R; Johnson J; Dettmar PW
    Biochem Pharmacol; 1984 Aug; 33(16):2553-7. PubMed ID: 6147143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.